The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALIGOS THERAPEUTICS INC | COM | 01626L105 | 10,837 | 476,547 | SH | SOLE | 476,547 | 0 | 0 | ||
| ALX ONCOLOGY HLDGS INC | COM | 00166B105 | 232,796 | 3,156,981 | SH | SOLE | 3,156,981 | 0 | 0 | ||
| ANNEXON INC | COM | 03589W102 | 4,444 | 159,622 | SH | SOLE | 159,622 | 0 | 0 | ||
| ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 2,095 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| ASLAN PHARMACEUTICALS LTD | ADS | 04522R101 | 7,705 | 2,300,000 | SH | SOLE | 2,300,000 | 0 | 0 | ||
| ATHIRA PHARMA INC | COM | 04746L104 | 18,599 | 1,010,812 | SH | SOLE | 1,010,812 | 0 | 0 | ||
| BCTG ACQUISITION CORP | COM | 05492W103 | 2,224 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 23,896 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
| BIOXCEL THERAPEUTICS INC | COM | 09075P105 | 17,264 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| BOLT BIOTHERAPEUTICS INC | COM | 097702104 | 4,937 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| C4 THERAPEUTICS INC | COM STK | 12529R107 | 4,177 | 112,928 | SH | SOLE | 112,928 | 0 | 0 | ||
| CEREVEL THERAPEUTICS HLDNG I | *W EXP 06/09/202 | 15678U102 | 144 | 33,333 | SH | SOLE | 33,333 | 0 | 0 | ||
| COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 9,205 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| CONNECT BIOPHARMA HLDGS LTD | ADS | 207523101 | 2,775 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| CULLINAN ONCOLOGY INC | COM | 230031106 | 17,229 | 413,458 | SH | SOLE | 413,458 | 0 | 0 | ||
| CYTOKINETICS INC | COM NEW | 23282W605 | 16,282 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
| DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 2,780 | 62,000 | SH | SOLE | 62,000 | 0 | 0 | ||
| DESIGN THERAPEUTICS INC | COM | 25056L103 | 81,702 | 2,732,501 | SH | SOLE | 2,732,501 | 0 | 0 | ||
| DYNE THERAPEUTICS INC | COM | 26818M108 | 49,764 | 3,204,392 | SH | SOLE | 3,204,392 | 0 | 0 | ||
| EARGO INC | COM | 270087109 | 2,498 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 34,346 | 1,056,812 | SH | SOLE | 1,056,812 | 0 | 0 | ||
| ELEDON PHARMACEUTICALS INC | COM | 28617K101 | 2,398 | 224,071 | SH | SOLE | 224,071 | 0 | 0 | ||
| FORMA THERAPEUTICS HLDGS INC | SHS | 34633R104 | 39,508 | 1,410,000 | SH | SOLE | 1,410,000 | 0 | 0 | ||
| FS DEVELOPMENT CORP II | COM CL A | 30318F100 | 2,988 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| HARMONY BIOSCIENCES HLDGS IN | COM | 413197104 | 3,304 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| HARPOON THERAPEUTICS INC | COM | 41358P106 | 6,276 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 3,357 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| HELIX ACQUISITION CORP | COM CL A | G4444C102 | 2,040 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| IKENA ONCOLOGY INC | COM | 45175G108 | 11,861 | 419,853 | SH | SOLE | 419,853 | 0 | 0 | ||
| INSTIL BIO INC | COM | 45783C101 | 46,319 | 1,846,850 | SH | SOLE | 1,846,850 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 7,416 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
| KARUNA THERAPEUTICS INC | COM | 48576A100 | 24,046 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| KEZAR LIFE SCIENCES INC | COM | 49372L100 | 4,768 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
| KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | 7,404 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| KINNATE BIOPHARMA INC | COM | 49705R105 | 29,122 | 934,602 | SH | SOLE | 934,602 | 0 | 0 | ||
| KYMERA THERAPEUTICS INC | COM | 501575104 | 10,139 | 260,920 | SH | SOLE | 260,920 | 0 | 0 | ||
| LANDOS BIOPHARMA INC | COM | 515069102 | 7,068 | 734,000 | SH | SOLE | 734,000 | 0 | 0 | ||
| LARIMAR THERAPEUTICS INC | COM | 517125100 | 3,360 | 230,000 | SH | SOLE | 230,000 | 0 | 0 | ||
| LUCIRA HEALTH INC | COM | 54948U105 | 3,025 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| NKARTA INC | COM | 65487U108 | 41,483 | 1,260,877 | SH | SOLE | 1,260,877 | 0 | 0 | ||
| NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 178 | 66,666 | SH | SOLE | 66,666 | 0 | 0 | ||
| OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 124,222 | 3,743,875 | SH | SOLE | 3,743,875 | 0 | 0 | ||
| PASSAGE BIO INC | COM | 702712100 | 2,185 | 125,010 | SH | SOLE | 125,010 | 0 | 0 | ||
| PMV PHARMACEUTICALS INC | COM | 69353Y103 | 6,578 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| REPARE THERAPEUTICS INC | COM | 760273102 | 27,621 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||
| RESEARCH ALLIANCE CORP II | COM CL A | 760873109 | 3,075 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| SILVERBACK THERAPEUTICS INC | COM | 82835W108 | 5,454 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| THERAPEUTICS ACQUISITION COR | COM CL A | 88339T103 | 5,255 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| TURNING POINT THERAPEUTICS I | COM | 90041T108 | 13,243 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
| UNUM THERAPEUTICS INC | COM | 19240Q201 | 12,472 | 1,420,500 | SH | SOLE | 1,420,500 | 0 | 0 | ||
| VINCERX PHARMA INC | COM NEW | 92731L106 | 9,264 | 480,000 | SH | SOLE | 480,000 | 0 | 0 | ||
| VIRACTA THERAPEUTICS INC | COM | 92765F108 | 4,348 | 470,000 | SH | SOLE | 470,000 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 9,191 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||